Abstract：
:Transcriptomic screens in breast cancer cell lines have identified a protein named anterior gradient-2 (AGR2) as a potentially novel oncogene overexpressed in estrogen receptor (ER) positive tumours. As targeting the ER is responsible for major improvements in cure rates and prevention of breast cancers, we have evaluated the pro-oncogenic function of AGR2 in anti-hormone therapeutic responses. We show that AGR2 expression promotes cancer cell survival in clonogenic assays and increases cell proliferation and viability in a range of cancer cell lines. Chromatin immunoprecipitation and reporter assays indicate that AGR2 is transcriptionally activated by estrogen through ERalpha. However, we also found that AGR2 expression is elevated rather than inhibited in response to tamoxifen, thus identifying a novel mechanism to account for an agonistic effect of the drug on a specific pro-oncogenic pathway. Consistent with these data, clinical analysis indicates that AGR2 expression is related to treatment failure in ERalpha-positive breast cancers treated with tamoxifen. In contrast, AGR2 is one of the most highly suppressed genes in cancers of responding patients treated with the anti-hormonal drug letrozole. These data indicate that the AGR2 pathway represents a novel pro-oncogenic pathway for evaluation as anti-cancer drug developments, especially therapies that by-pass the agonist effects of tamoxifen.
journal_name
Oncogenejournal_title
Oncogeneauthors
Hrstka R,Nenutil R,Fourtouna A,Maslon MM,Naughton C,Langdon S,Murray E,Larionov A,Petrakova K,Muller P,Dixon MJ,Hupp TR,Vojtesek Bdoi
10.1038/onc.2010.228subject
Has Abstractpub_date
2010-08-26 00:00:00pages
4838-47issue
34eissn
0950-9232issn
1476-5594pii
onc2010228journal_volume
29pub_type
杂志文章相关文献
ONCOGENE文献大全abstract：:Despite the clonal origin of most tumors, their tremendous heterogeneity suggests that cancer progression springs from the combined forces of both genetic and epigenetic events, which produce variant clonal populations, together with the selective pressures of the microenvironment, which promote growth and, perhaps, d...
journal_title：Oncogene
pub_type： 杂志文章,评审
doi：10.1038/sj.onc.1206955
更新日期：2003-09-29 00:00:00
abstract：:We studied the role of the mitogen-activated protein kinase (MAPK) pathway in the regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in breast tumor MCF-7 cells. We found that addition of a protein kinase C (PKC) activator to MCF-7 cultures prevented TRAIL-induced apoptosi...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1205523
更新日期：2002-06-20 00:00:00
abstract：:p27Kip1 plays an important role in cell cycle progression by negatively regulating the activity of cyclin-Cdk complexes. To understand how p27Kip1 functions, the level and subcellular location of p27Kip1 in Swiss/3T3 cells following serum stimulation of quiescent cells was examined. Surprisingly, p27Kip1 was observed ...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1202912
更新日期：1999-09-16 00:00:00
abstract：:We have previously demonstrated that the expression of FGFR3 is frequently downregulated in colorectal carcinoma cells. Here we have shown that FGFR1 is overexpressed in colorectal carcinoma cells and the gene expressions between FGFR1 and FGFR3 are mutually exclusive. Moreover, we have also shown that the disruption ...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1208254
更新日期：2005-01-27 00:00:00
abstract：:Platelet-derived growth factor (PDGF) and vascular endothelial growth factor define a family of dimeric proteins characterized by eight conserved cysteine residues involved in disulfide bonds. Thirteen non-cysteine residues conserved among the platelet-derived/vascular endothelial growth factors were individually muta...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1993-03-01 00:00:00
abstract：:The inactivation of certain tumor suppressor genes is thought to play an important role in the genesis of a number of tumor types. For example, inactivation of the Retinoblastoma (Rb) tumor suppressor is frequently observed in a proportion of sporadic human breast cancers. While these studies suggest that inactivation...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1201707
更新日期：1998-04-16 00:00:00
abstract：:Members of the Myc proto-oncogene family encode transcription factors that function in multiple aspects of cell behavior, including proliferation, differentiation, transformation and apoptosis. Recent studies have shown that MYC activities are modulated by a network of nuclear bHLH-Zip proteins. The MAX protein is at ...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1201611
更新日期：1998-02-26 00:00:00
abstract：:Tamoxifen (Tam), besides its action as an anti-estrogen, also inhibits cell proliferation of estrogen receptor (ER)-negative cancer cells by an unknown mechanism. In this study, we used ER-negative lung cancer cells to clarify such ER-independent inhibitory effect of Tam. We found that Tam induced G1 growth arrest in ...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1202755
更新日期：1999-07-22 00:00:00
abstract：:Treatment options for adenoid cystic carcinoma (ACC) of the salivary gland, a slowly growing tumor with propensity for neuroinvasion and late recurrence, are limited to surgery and radiotherapy. Based on expression analysis performed on clinical specimens of salivary cancers, we identified in ACC expression of the neu...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2012.377
更新日期：2013-08-08 00:00:00
abstract：:L-ascorbate (L-ascorbic acid, vitamin C) clearly has an inhibitory effect on cancer cells. However, the mechanism underlying differential sensitivity of cancer cells from same tissue to L-ascorbate is yet to be clarified. Here, we demonstrate that L-ascorbate has a selective killing effect, which is influenced by sodi...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2012.176
更新日期：2013-03-21 00:00:00
abstract：:Lin28b is an RNA-binding protein that inhibits biogenesis of let-7 microRNAs. LIN28B is overexpressed in diverse cancers, yet a specific role in the molecular pathogenesis of colon cancer has to be elucidated. We have determined that human colon tumors exhibit decreased levels of mature let-7 isoforms and increased ex...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2011.131
更新日期：2011-10-06 00:00:00
abstract：:Loss of RASSF1A leads to several mitotic abnormalities, including cytokinesis failure and tetraploidization. Uncontrolled proliferation of tetraploid cells is known to trigger genomic instability and tumor development and is normally prevented through activation of a p53-dependent tetraploidy checkpoint. RASSF1A is th...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2010.440
更新日期：2011-02-10 00:00:00
abstract：:Microsatellite-stable, near-diploid (MSI-CIN-) colorectal carcinomas have been reported, but it is not clear as to whether these tumours form a discrete group or represent one end of the distribution of MSI-CIN+ cancers. In order to address this question, we screened 23 MSI-CIN- colorectal cancers for gains and losses...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1208194
更新日期：2005-01-06 00:00:00
abstract：:T-cell acute lymphoblastic leukemia (T-ALL) frequently involves aberrant expression of TAL1 (T-cell acute lymphocytic leukemia 1) and LMO2, oncogenic members of the TAL1 transcriptional complex. Transcriptional activity of the TAL1-complex is thought to have a pivotal role in the transformation of thymocytes and is as...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2015.481
更新日期：2016-08-04 00:00:00
abstract：:Approximately a third of all drugs act by binding directly to cell surface receptors coupled to G proteins. Other drugs act indirectly on these same pathways, for example, by inhibiting neurotransmitter reuptake or by blocking the inactivation of intracellular second messengers. These drugs have revolutionized the tre...
journal_title：Oncogene
pub_type： 杂志文章,评审
doi：10.1038/sj.onc.1210416
更新日期：2007-05-14 00:00:00
abstract：:Inhibition of apoptosis or abnormal cell survival can result in tumorigenesis by facilitating the insurgence of various mutations. Immediate-early response gene X-1 (IEX-1), protects T cells from apoptosis induced by the ligation of Fas or the T-cell receptor (TCR)/CD3 complex in Emu-IEX-1 mice that direct the gene ex...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1206707
更新日期：2003-10-09 00:00:00
abstract：:Wilms tumours (WTs) have two distinct types of histology with or without ectopic mesenchymal elements, suggesting that WTs arise from either the mesenchymal or epithelial nephrogenic lineages. Regardless of the presence or absence of CTNNB1 mutations, nuclear accumulation of beta-catenin is often observed in WTs with ...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2008.455
更新日期：2009-02-26 00:00:00
abstract：:Oxygen is the ultimate source of oxidizing power for disulfide bond formation, suggesting that under limiting oxygen proper protein folding might be compromised. We show that secretion of vascular endothelial growth factor (VEGF), a protein with multiple disulfide bonds, was indeed impeded under hypoxia and was partia...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1208325
更新日期：2005-02-03 00:00:00
abstract：:Knowledge of tumour initiation in human epithelia is limited by sample availability and difficulty in experimental manipulation of human cells. The thyroid is a useful model since, in addition to multiple tumour stages, it presents two distinct 'pathways' of tumorigenesis: 'follicular' tumours, in which ras oncogene m...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1994-01-01 00:00:00
abstract：:Transforming growth factor beta1 (TGF-beta1) belongs to a family of polypeptide factors, whose cytostatic and apoptotic functions help restrain the growth of mammalian cells. Although solid data established the role of TGF-beta's as suppressor factors in tumorigenic processes, in the context of an advanced stage of di...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1208664
更新日期：2005-06-30 00:00:00
abstract：:In Dictyostelium discoideum, three ras genes (rasD, rasG and rasB) and one ras-related gene (rap1) have been previously isolated and characterized, and the deduced amino acid sequence of their predicted protein products share at least 50% sequence identity with the human H-Ras protein. We have now cloned and character...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1994-02-01 00:00:00
abstract：:The RAS-RAF-MEK-ERK signaling cascade is among the most frequently mutated pathways in human cancer. Approximately 50% of melanoma patients possess a druggable hotspot V600E/K mutation in the BRAF protein kinase. FDA-approved combination therapies of BRAF and MEK inhibitors are available that provide survival benefits...
journal_title：Oncogene
pub_type： 杂志文章,评审
doi：10.1038/s41388-018-0171-x
更新日期：2018-06-01 00:00:00
abstract：:Cbl-b, a mammalian homolog of Cbl, consists of an N-terminal region (Cbl-b-N) highly homologous to oncogenic v-Cbl, a Ring finger, and a C-terminal region containing multiple proline-rich stretches and potential tyrosine phosphorylation sites. In the present study, we demonstrate that upon engagement of the T cell rec...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1202411
更新日期：1999-02-04 00:00:00
abstract：:The few imprinted genes characterized so far include the insulin-like growth factor-2 gene (IGF2) coding for a foetal growth factor and the H19 gene whose normal function is unknown but which is likely to act as an RNA with an antitumour effect. IGF2 is expressed by the paternal allele and H19 by the maternal allele. ...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1996-01-18 00:00:00
abstract：:Cancer is classically considered as a genetic and, more recently, epigenetic multistep disease. Despite seminal studies in the 1920s by Warburg showing a characteristic metabolic pattern for tumors, cancer bioenergetics has often been relegated to the backwaters of cancer biology. This review aims to provide a histori...
journal_title：Oncogene
pub_type： 历史文章,杂志文章,评审
doi：10.1038/onc.2011.576
更新日期：2012-09-06 00:00:00
abstract：:Dasatinib, a dual Src family kinase and Abl inhibitor, is being tested clinically for the treatment of prostate cancer bone metastasis. Bidirectional interactions between osteoblasts and prostate cancer cells are critical in the progression of prostate cancer in bone, but the effect of dasatinib on osteoblasts is unkn...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2010.73
更新日期：2010-06-03 00:00:00
abstract：:In order to examine the role of p53 expression on the sensitivity of cells to radiation-induced reproductive failure, we examined the radiosensitivity of a human diploid fibroblast cell strain (AG1521) before and after transfection with the E6 or E6/E7 genes of human papillomavirus 16 (HPV16)3. HPV E6 binds to p53, pr...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1995-06-15 00:00:00
abstract：:p73 and p63 are two recently discovered p53 homologs. Like p53, these proteins can recognize canonical p53 DNA-binding sites and, when overproduced, can activate p53-responsive target genes and induce apoptosis. Unlike p53, these genes undergo complex alternative splicing which, at least in the case of p63, yields pro...
journal_title：Oncogene
pub_type： 杂志文章,评审
doi：10.1038/sj.onc.1202955
更新日期：1999-12-13 00:00:00
abstract：:The MT-2 cell-line, which had been established through in vitro cell to cell transmission of human T-cell leukemia virus type I (HTLV-I) among human primary lymphocytes, was shown to possess multiple copies of integrated proviruses, including defective proviral genomes. By analysing a genomic clone, we identified the ...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1996-04-04 00:00:00
abstract：:Homeobox genes encode transcription factors that are essential for normal development and are often dysregulated in cancers. The molecular mechanisms that cause their misregulation in cancers are largely unknown. In this study, we investigate the mechanism by which the Six1 homeobox protein, which has a crucial role d...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2010.233
更新日期：2010-09-02 00:00:00
